Developing a new type of vascular graft to improve heart surgery outcomes
Preclinical Assessment of a Compliance Matched Biopolymer Vascular Graft
['FUNDING_R01'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-10996136
This study is testing a new type of heart bypass graft that is designed to work better with your blood vessels and last longer after surgery, making it a great option for people needing coronary artery bypass surgery.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-10996136 on ClinicalTrials.gov |
What this research studies
This research focuses on creating a new type of vascular graft designed to improve the success rates of coronary artery bypass graft (CABG) surgeries. It aims to address the issue of graft failure, which can occur due to mismatched compliance between the graft and the patient's blood vessels. By engineering a biodegradable graft that maintains its compliance during the healing process, the researchers hope to enhance the graft's performance and longevity. The approach involves using advanced tissue engineering techniques and computational simulations to optimize the graft's properties before implantation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals undergoing coronary artery bypass graft surgery, particularly those at risk of graft failure.
Not a fit: Patients who are not candidates for coronary artery bypass graft surgery or those with non-coronary heart diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved outcomes for patients undergoing heart bypass surgeries, reducing the risk of graft failure.
How similar studies have performed: Previous research in tissue engineering has shown promise in developing vascular grafts, but this specific approach to compliance matching is relatively novel.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VANDE GEEST, JONATHAN PIETER — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: VANDE GEEST, JONATHAN PIETER
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.